Wikipedia -WSS

Wikipedia

author：explore 2025-09-28 21:58:48 - browse：7387

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： New safety details link Apellis eye drug to rare cases of blindness

explore

WSS

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Bird flu reported in person exposed to presumably infected cattle

Pancreatic cancer is often deadly, but new discoveries are raising hope

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Wildfire pollution widens asthma inequities on Long Island

Breakthrough Alzheimer’s drugs are inaccessible in rural states

leisure time

Wikipedia

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

Gut bacteria may contribute to kidney autoimmunity, study finds

Psychedelics group wrestles with new pharma identity

Florida Supreme Court upholds state's abortion ban

ChatGPT in medicine: STAT answers readers' burning questions

Republican states more likely to report Covid vaccine side effects

Hepatitis C has a cure — but many Americans still lack access to it

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Heart attack and stroke risk calculators need revising

The high personal cost of affirmative action for Black doctors

focus

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Scientists uncover potential path to treating deadly childhood tumor

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Oral obesity drug from Viking Therapeutics hits key early target

No plane should take off without an EpiPen onboard

Trial using CRISPR to edit HIV out of cells disappoints

knowledge

focus

explore

focus